Form 4: Avid Bioservices Director Exercises and Acquires Shares Through Vesting of Restricted Stock Units

Director Esther M. Alegria exercised and acquired shares of Avid Bioservices stock through the vesting of restricted stock units on December 14, 2024.

Summary

• Director Esther M. Alegria exercised 26,756 restricted stock units (RSUs) that vested on December 14, 2024, converting them into common stock.
• These RSUs were granted on December 14, 2023, as part of the company's non-employee director compensation program.
• Additionally, Ms. Alegria was granted 8,147 new RSUs on December 14, 2024, which will vest on December 14, 2025, subject to continued service.
• Following these transactions, Ms. Alegria directly owns 8,147 RSUs and 37,746 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally positive for alignment of interests. There are no indications of negative sentiment.

Positives

• The vesting of RSUs indicates that the director has met the service requirements for the previous year.
• The grant of new RSUs aligns the director's interests with the company's long-term performance.

Risks

• The vesting of RSUs could potentially lead to a slight increase in the number of shares available in the market if the director chooses to sell the shares.

Future Outlook

The newly granted RSUs will vest on December 14, 2025, subject to the director's continued service.

Industry Context

This is a standard transaction for a director's equity compensation in a publicly traded company. It is common for directors to receive stock-based compensation that vests over time.

Comparison to Industry Standards

• Equity compensation, such as restricted stock units, is a common practice for directors in publicly traded companies across various industries.
• The vesting schedule of one year for the initial grant and another year for the new grant is fairly standard.
• Companies like Catalent and Lonza also use similar equity compensation structures for their board members.

Stakeholder Impact

• The vesting of RSUs and the grant of new RSUs are not expected to have a significant impact on shareholders.
• The transactions are part of the standard compensation package for the director.

Next Steps

• The director will continue to serve on the board, and the newly granted RSUs will vest on December 14, 2025, if service requirements are met.

Key Dates

Keywords

Avid Bioservices, Director, Esther M. Alegria, Restricted Stock Units, RSU, Vesting, Equity Compensation, SEC Form 4, CDMO